Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
Antiviral Research|April 22, 2014
E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settingsNicolas Sluis-Cremer, Michael R Jordan, Kelly Huber, et al.The Journal of Biological Chemistry|June 29, 2005
Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)Daniel W Lambert, Mike Yarski, Fiona J Warner, et al.Antimicrobial Agents and Chemotherapy|September 12, 2012
Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility dataEdward P Acosta, Kay L Limoli, Lan Trinh, et al.Journal of Viral Hepatitis|January 3, 2024
Context-dependent accuracy of the cobas plasma separation card for HCV RNA viral load measurementHuma Qureshi, Ana Carrasco Duran, Hassan Mahmood, et al.European Journal of Biochemistry|June 9, 2004
The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor proteinTobias M J Allinson, Edward T Parkin, Thomas P Condon, et al.Journal of Virology|April 29, 2005
Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1Javier Martinez-Picado, Terri Wrin, Simon D W Frost, et al.Biochimica Et Biophysica Acta|October 27, 2007
Membrane raft actin deficiency and altered Ca2+-induced vesiculation in stomatin-deficient overhydrated hereditary stomatocytosisD Katie Wilkinson, E Jane Turner, Edward T Parkin, et al.Journal of Virological Methods|July 30, 2013
Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravirThomas P Young, Laura A Napolitano, Agnes C Paquet, et al.Environmental Science & Technology|May 31, 2003
Risk-based approach to evaluate the public health benefit of additional wastewater treatmentJeffrey A Soller, Adam W Olivieri, James Crook, et al.Journal of Virology|November 21, 2008
In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudineRoger Paredes, Manish Sagar, Vincent C Marconi, et al.Pageof 13